NCT05716932View on ClinicalTrials.gov

Focal Laser Single Intravitreal Ranibizumab Retinal Artery Macroaneurysm.

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

December 22, 2022

Primary Completion Date

January 21, 2023

Study Completion Date

January 21, 2023

Conditions
Retinal Artery Macroaneurysm
Interventions
PROCEDURE

Dual focal laser and intravitreal Ranibizumab injection

Direct and perilesional focal laser followed by a single intravitreal 0.5 mg ranibizumab (Lucentis, Genentech, Inc., South San Francisco, CA, USA) injection

Trial Locations (1)

12311

Kasr alainy faculty of medicine, Cairo

All Listed Sponsors
collaborator

Cairo University

OTHER

lead

Dar El Oyoun Hospital

OTHER